164 results
Page 3 of 9
6-K
EX-99.1
1e0qk
14 Oct 21
51-102F3 Material Change Report
4:00pm
6-K
EX-99.1
m5stww7
13 Oct 21
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
12:00am
6-K
EX-99.1
dgazouwrrwn4
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.2
iktsz98h
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
5aa0f80r1bdo34e
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm
6-K
EX-99.1
g8b prr1n
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.3
wefoixxh7u e9es172
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.1
fak9 cimlmq
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
9lpke91b p8
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.6
h33xoycomnsw02e
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
zg0p2
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
jbz wglat
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
wa1wkpbc wa
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
3dcp537494p58rkhsm
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
t3o5y 60k5i
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
usb1jpa1r8h k0
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.3
9ltl9rfl7 z3
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
ksxas6 jkmz3mhfrwku
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
z72ecf57
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
vdvovil4 tma8h
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am